Trial
NCT02366819
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Phase IVSUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Chicago
Collaborators
National Cancer Institute (NCI)
Condition
Esophageal Adenocarcinoma
Intervention
Oxaliplatin
Why stopped
Pending data analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-30